Background/Aims: Lung cancer (LC) continues to be one of the most prevalent cancers around the world. During this study we aimed to investigate the involvement of endoplasmic reticulum stress (ERS) in autophagy, apoptosis, and chemotherapy resistance of mutant p53 LC cells. Methods: Immunohistochemistry was employed to help determine the p53 mutation status of cancer cells from 92 primary LC patients, who were subsequently assigned to either the mutant p53 (n = 39) or wild-type p53 group (n = 53). Results: Mutant p53 cells exhibited increased expression of the C/EBP homologous protein (CHOP), glucose-regulated protein 78 (GRP78), and inositol-requiring enzyme-1α (IRE1α). The Mutant p53 cells were also found to be sensitive to chemotherapy and displayed decreased expression of PI3K, Akt, and mTOR. The mutant p53 cell lines were treated with tunicamycin to induce ERS and rapamycin in order to inhibit mTOR. Both agents increased the expression of CHOP, GRP78, IRE1α, LC3-II/LC3-I, Atg5, Atg7, caspase-3, caspase-12, cleaved caspase-3, cleaved caspase-12, as well as decreases in cell proliferation as well as the expression levels of PI3K, Akt, and mTOR. Enhanced levels of cell apoptosis and reduced chemotherapy resistance were also detected. Conclusion: The findings of our study suggest that ERS promotes autophagy and apoptosis, while acting to reduce chemotherapy resistance in mutant p53 LC cells by downregulating the PI3K/Akt/mTOR signaling pathway.
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Introduction
Lung cancer (LC), is characterized by unrestrained cell growth in lung tissues [1] . As one of the most common malignant tumors worldwide, the leading risk factors involved with the occurrence of LC include both smoking as well as exposure and environmental factors treatments. The relevant patient clinical data were made record of. The tumor-node-metastasis (TNM) cancer staging adopted in this study was based on the staging criteria published jointly by the American Joint Committee on Cancer (AJCC) and the International Union Against Cancer (UICC) [31] . All patients in our study were at stages III~IV. The patients were grouped according to the immunohistochemistry staining of their respective tumors, namely: the mutant p53 group (39 patients) or the wild-type p53 group (53 patients) . The patients in the mutant p53 and wild-type p53 groups were comparable in relation to age, sex, histological differentiation, pathological type, smoking, and lymph node metastasis.
Chemotherapy Regimens
Lung adenocarcinoma patients were administered pemetrexed (PEM) + cisplatin (DDP) treatment: PEM 500 mg/m 2 on day 1 + DDP 75 mg/m 2 on day 1. Patients with squamous cell carcinoma received gemcitabine (GEM) + DDP treatment: GEM 1000 mg/m 2 on days 1 and 8 + DDP 75 mg/m 2 on day 1. After 6 weeks of chemotherapy, chest computed tomography (CT) scans were conducted to assess the chemotherapy effects. Patients were then classified as having complete remission (CR), partial remission (PR), stable disease (SD), or progressive disease (PD) in accordance with the Response Evaluation Criteria in Solid Tumors (RECIST) [32] . For evaluation purposes, patients with CR + PR + SD were considered as responders, while patients with PD were considered to be non-responders.
Cell Grouping and Transfection
H322 and NCI-H157 LC cell lines with a p53 mutation were purchased from the Shanghai Cell Bank of Chinese Academy of Sciences (Shanghai, China), and cultured in high glucose complete Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS), 100 u/ml penicillin, and 100 u/ml streptomycin. After digestion and passage in a 0.25% trypsin solution, the cells were incubated at 37°C with 5% CO 2 and saturated humidity. After 2 passages, the H322 as well as the NCI-H157 cells were divided into the blank group, the ERS group, the ERS + 4-phenylbutyrate acid (PBA) group, the rapamycin group, or the ERS + rapamycin group. The cells in the blank group received no further treatment. In the ERS group, the cells were treated with 10 mg/l tunicamycin (Batch number: YO7980200; Sigma-Aldrich Chemical Company, St Louis, MO, USA), an ER agonist, to induce ERS over a 24 h period. In the ERS + 4-PBA group, the cells were initially treated with 10 mg/l tunicamycin, followed by treatment with 10 mg/l 4-PBA (Batch number: 2013 + ; Sigma-Aldrich Chemical Company, St Louis MO, USA), and a small molecular chemical chaperone, in order to terminate ERS. In the rapamycin group, the cells were treated with 10 nmol/l rapamycin (Batch number: S17098; Shanghai Zhongkang Weiye Biological Science & Technology Co., Ltd, Shanghai, China) to suppress the PI3K/AKT/mTOR signaling pathway. In the ERS + rapamycin group, the cells were initially treated with 10 mg/l tunicamycin and then with 10 nmol/l rapamycin.
Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR)
Total RNA from H322 and NCI-H157 cells was isolated using a Trizol kit (Batch number: 2 O. The reaction conditions for reverse transcription process was conducted at 37°C for 30 min, followed by 85°C for 6 s. qRT-PCR was conducted using the SYBR Premix Ex Taq II Kit (Batch number: 1398; Takara Holdings Inc., Kyoto, Japan). A reaction system of 20 μl was prepared with 1 μl of RT-PCR product, 10 μl of 2 × SYBR Green I Premix Ex Taq II, 0.8 μl of 10 μm PCR Forward Primer, 0.8 μl of 10 μm PCR Reverse Primer, 0.4 μl of 50 × ROX Reference Dye, and 7 μl of dH 2 O. The reaction conditions were as follows: initial denaturation at 95°C for 30 s, 95°C for 5 s, 56°C for 30 s and 72°C for 30 s for a total of 40 cycles. The 2 -DDCT method was adopted to calculate the relative expression levels of target genes; the data were displayed as the relative expression. Each sample experiment was repeated three times. The reference gene for the ERS markers, included C/EBP homologous protein (CHOP), glucoseregulated protein 78 (GRP78), inositol-requiring enzyme-1α (IRE1α), LC3-I, LC3-II, autophagy-related gene 5 (Atg5), autophagy-related gene 7 (Atg7), caspase-3, caspase-12, PI3K, Akt and mTOR, was glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The primer sequences are displayed in Table 1 .
Western Blotting
After one or two passages, the LC cell lines were washed three times with FBS (Batch number: 1036489; Thermo Fisher Scientific, San Jose, California, USA) and placed on ice for 30 min. Total protein was extracted and quantified using a bicinchoninic acid (BCA) protein assay kit (Batch number: 20140312; Beyotime Biotechnology Co., Shanghai, China). Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels were prepared, and the sample volume was calculated on the basis of the relative protein concentration, followed by even mixing with SDS loading buffer at a ratio of 1: 1. The mixture was heated in a boiling water bath for 5 min, and the samples were then subsequently added. Next, a 5% concentration gel and a 12% separation gel were selected for electrophoresis at 80 V and 100 V, respectively. The gels were then cut and marked by beveling, and the interlayer was subjected to a constant current of 200 mA electrophoretic transfer at 4°C for 2 h. After blocking with 5% nonfat dried milk for 1 h at room temperature, the membrane was then washed 3 times with Tris-Buffered Saline Tween-20 (TBST), with each wash lasting 10 min. The primary antibodies were all incubated at 4°C overnight, including CHOP (1 : 750; YB532; Shanghai Yu Bo Biological Technology Co., Ltd, Shanghai, China), GRP78 (1 : 1000; ab21685), IRE1α (1 : 1000; ab37073), anti-PI3K (1 : 1000; #4249), anti-AKT (1: 1000; #4685), anti-mTOR (1 : 1000; #2983), caspase-3 (1 : 1000; #9665), caspase-12 (1 : 1000; #2202), Atg5 (1 : 1500; ab10832), Atg7 (1 : 150000; ab52472), LC3 (1 : 1500; ab48394) and rabbit anti-human β-actin polyclonal antibody (1 : 4000; ab5694). The membranes were then washed with TBST 3 times, with each wash lasting 10 min, followed by incubation with horseradish peroxidase (HRP)-labeled goat anti-rabbit immunoglobulin G (IgG) (Batch number: SN134; Nanjing SunShine Biotechnology Co., Ltd, Nanjing, China) at room temperature for 1 h. The total protein was subsequently detected by means of Enhanced Chemical Luminescence (ECL) (Batch number: ml01146; Shanghai Meilian Biological Technology Co., Ltd, Shanghai, China), and scanned using the gel imaging system and analysis tool from the ImageJ software. Each sample experiment was performed three times. β-actin was used as the internal control, and the relative expression levels of COPH, GRP78, IRE1α, PI3K, Akt, mTOR, caspase-3 and LC3-II/LC3-I in each group were subsequently calculated. GRP78, IRE1 alpha, Atg5, Atg7, LC3 and β-actin antibodies were purchased from Abcam (Abcam Inc., Cambridge, MA, USA), while PI3K, Akt, mTOR, caspase-3, and caspase-12 antibodies were purchased from Cell Signaling Technology (Beverly, MA, USA).
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Flow Cytometry
After subculturing for 2 or 3 passages, LC cells were seeded into a 12-well plate with a cell concentration of 4 × 10 4 . After collecting the supernatant, phosphate buffer saline (PBS) was used to wash the adherent cells twice at 37°C. Then, the adherent cells were collected and digested with 0.25% trypsin (without ethylene diamine tetraacetic acid [EDTA] ). The digestion was terminated by adding PBS containing 2% bovine serum albumin (BSA) at 4°C. After being mixed, the cells were placed in a centrifuge tube and centrifuged at 1800 rpm for 10 min. Next, the cells were washed once again with PBS, resuspended, filtered through a 400-mesh screen, counted, and centrifuged again. The supernatant was then discarded. The cell concentration was adjusted to 1 × 10 6 by adding 500 μl of cold binding buffer. Then, 5 μl of Annexin V-fluorescein isothiocyanate (FITC) was added, and the cells were incubated under dark conditions, at 4°C for 30 min. Next, the mixture was gently oscillated with 400 µl of binding buffer. Over a period of 1 h, quantitative analyses were conducted using a flow cytometer (FACS Aria TM , Becton, Dickinson, and Company, NJ, USA)
3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay
PBS was used to prepare the MTT solution (Batch Number: 834008; Sigma-Aldrich Chemical Company, St Louis, MO, USA). H322 and NCI-H157 cells were first added to 96-well plates (5 × 10 3 cells/well), and DDP was then added to the culture for 24 h at concentrations of 0, 25, 50, 100, 200, and 400 µmol/l. The 0 µmol/l group was regarded as the control group, and DMEM high-glucose complete medium (Batch Number: 4832; Sigma-Aldrich Chemical Company, St Louis, MO, USA) containing no cells was used as the blank group. The optical density (OD) at 570 mm was measured. The survival rate and inhibition rate of each group were calculated according to the following formula; The cell survival rate (%) = (the OD value in the ERS groups -the OD value in the blank group/the OD value in the control group -the OD value in the blank group) × 100%. The cell inhibition rate (%) = 1 -the cell survival rate (%). The half maximal inhibitory concentration (IC50) of cisplatin in each cell was calculated using SPSS 20 (IBM Corp. Armonk, NY, USA). Each group assay was repeated 3 times.
5-bromo-2'deoxyuridine (BrdU) Cell Proliferation Assay
H322 and NCI-H157 cells were selected and seeded into a 24-well plate at 5 × 10 4 cells/well. DDP at a concentration of 200 µmol/l was added and incubated over the following 24 h. Next, 10 µM BrdU was added to each well and incubated for 4 h. Then, 4% pre-cooled paraformaldehyde was added for 20 min to fix the cells, and the cells were washed 3 times with PBS. The cells were then permeabilized with 0.2% Triton X-100 for 10 min and washed with PBS 3 times. BrdU antibody was diluted at a ratio of 1: 100, and 300 µl was added to each well and incubated at 4°C overnight. After washing with PBS 3 times, TRITC-labeled fluorescent second antibody (1: 1000) was added, and the samples were then baked in an oven at 37°C. DAPI (0.5 µg/ml) was applied to stain the nuclei, distilled water was used to rinse off the PBS, glycerol was used for mounting, and the number of positive cells was counted under an inverted microscope. The assay was repeated three times for each group.
Clonogenic Assay
After subculturing for 2 or 3 generations, the LC cells were incubated in a 6-well plate at a concentration of 150 cells/ml. There were 300 cells per well with 3 duplicate wells for each group. When the cells began to adhere, 200 µmol/l DDP was added, and the cells were subsequently cultured for 5 days. The adherent cells were then washed 3 times with PBS, fixed in 4% paraformaldehyde and stained with crystal violet for 10 min. After rinsing with water, microscopy was used to observe colony formation. The plating efficiency (PE) = colony formation number/seeded cell number × 100%.
Statistical Analysis
A minimum of three repeats were conducted for each experiment under identical conditions. SPSS 20.0 (IBM Corp. Armonk, NY, USA) was used for statistical analyses. All data were expressed as the mean ± standard deviation. Continuous data were analyzed using the independent-sample t-test method. Comparisons between groups were analyzed by analysis of variance (ANOVA) or by means of t-test. Categorical data were presented as percentage or ratio. P < 0.05 was considered to be statistically significant.
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Results
Correlation of Mutant p53 and Wild-Type p53 with Clinical Characteristics in NSCLC patients
p53 mutation status was connected to the NSCLC differentiation, TNM stage, and lymph node metastasis (all P < 0.05) however, no significant correlation was detected in regard age, sex, smoking or pathological type (all P > 0.05, Table 2 )
Mutant p53 Cells Had Increased Expression Levels of CHOP, GRP78 and IRE1α and Decreased Expression Levels of PI3K, Akt and mTOR and Were Sensitive to Chemotherapy
Compared with the wild-type p53 LC cells, mutant p53 LC cells displayed higher mRNA and protein levels of CHOP, GRP78, and IRE1α and lower expression levels of PI3K/Akt/ mTOR signaling pathway-related proteins (all P < 0.05, Fig. 1 ). In addition, of the 92 advanced NSCLC patients who underwent chemotherapy, there were 39 patients with mutant p53 as well as 53 patients with wild-type p53. After 6 weeks of chemotherapy, in the patients with mutant p53, chemotherapy was confirmed to be effective (CR + PR + SD) in 31 patients, Relative protein expression levels of CHOP, GRP78, IRE1α, PI3K, AKT and mTOR in the mutant and wild-type p53 groups; C. Relative mRNA expression levels of CHOP, GRP78, IRE1α, PI3K, AKT and mTOR in the mutant and wild-type p53 groups; * P < 0.05, indicates a comparison with P53-wild-type group; CHOP, C/EBP homologous protein; GRP78, glucose-regulated protein 78; IRE1α, inositolrequiring enzyme-1α; PI3K, phosphatidyl inositol 3-kinase; Akt, protein kinase B; mTOR, mammalian target of rapamycin. 
Cellular Physiology
However, compared with those in the blank group, the mRNA and protein expression levels of PI3K, AKT and mTOR in the ERS and ERS + rapamycin groups were displayed notably reduced levels (P < 0.05). The detected expressions of PI3K and AKT were not significantly different in the rapamycin group (P > 0.05), but the mTOR expression was decreased notably (P < 0.05). The ERS + 4-PBA group had no significant differences regarding the mRNA and protein expression levels of PI3K, AKT and mTOR (P < 0.05). Compared with those in the ERS group, the ERS + 4-PBA group had increased mRNA and protein expression levels of PI3K, AKT and mTOR, while the rapamycin group displayed elevated levels of mRNA and protein expressions of both PI3K and AKT (all P < 0.05), with the exception of mTOR (P > 0.05); the ERS + rapamycin group had decreased mTOR expression (all P < 0.05). No significant differences in the PI3K and AKT expression levels were detected (P > 0.05) (Fig. 3) .
ERS Alters the Levels of Autophagic Cytokines (LC3-II/LC3-I, Atg5, and Atg7) in Mutant p53 LC Cells
Compared the levels observed in the blank group (Fig. 4) , the levels of LC3-II/LC3-I, Atg5, and Atg7 in the mutant p53 LC cells in the ERS, rapamycin and ERS + rapamycin groups 
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all displayed significantly upregulated rates (all P < 0.05). No significant difference was found in the ERS + 4-PBA group (all P > 0.05). Compared with those in the ERS group, significant decreases in the levels of LC3-II/LC3-I, Atg5, and Atg7 were detected in the ERS + 4-PBA group (all P < 0.05); no significant differences were observed in the rapamycin group (all P > 0.05), however, significantly increased levels of LC3-II/LC3-I, Atg5, and Atg7 were observed in the ERS + rapamycin group (all P < 0.05).
ERS Increases the Number of Autophagosomes Formed in Mutant p53 LC Cells
As displays in Fig. 5 , the autophagosome formation could be observed by fluorescence microscopy after GFP-LC3 fusion proteins were translocated in mutant p53 LC cells. Compared with the blank group, autophagosome formation was significantly elevated in the ERS, rapamycin, and ERS + rapamycin groups (all P < 0.05). However, autophagosome formation in the ERS + 4-PBA group no significant difference was confirmed in relation to 
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the blank group (P > 0.05). Compared with that in the ERS group, autophagosome formation was exhibited notably decreased levels in the ERS + 4-PBA group (all P < 0.05); no significant difference was observed in the rapamycin group (all P > 0.05), however autophagosome formation was increased in the ERS + rapamycin group (all P < 0.05).
ERS Increases the Levels of Apoptotic Cytokines in Mutant p53 LC Cells
As displays in Fig. 6 , compared with the blank group, the levels of caspase-3, caspase-12, cleaved caspase-3 and cleaved caspase-12 in mutant p53 LC cells in the ERS, rapamycin and ERS + rapamycin groups were observed to have displayed marked increases (all P < 0.05), but no significant difference was detected in the ERS + 4-PBA group (P > 0.05). Compared with those in the ERS group, the levels of caspase-3, caspase-12, cleaved caspase-3 and cleaved caspase-12 were significantly decrease in the ERS + 4-PBA group (all P < 0.05); no significant differences were found in the rapamycin group (all P > 0.05), but the levels of caspase-3, caspase-12, cleaved caspase-3 and cleaved caspase-12 were increased in the ERS + rapamycin group (all P < 0.05).
ERS Increases the Apoptosis Rate in Mutant p53 LC Cells
In regard to the H322 cells, the apoptosis rates in the blank, ERS, ERS + 4-PBA, rapamycin, and ERS + rapamycin groups were 3.36%, 17.65%, 4.53%, 18.41%, and 26.34%, respectively. The ERS + rapamycin group had the highest apoptosis rate. In NCI-H157 cells, the apoptosis rates in the blank, ERS, ERS + 4-PBA, rapamycin, and ERS + rapamycin groups were 5.18%, 16.75%, 5.43%, 17.41%, and 28.14%, respectively. Compared with those in the blank group, the apoptosis rates of the mutant p53 LC cells in the ERS group, the rapamycin group and the ERS + rapamycin group all displayed significant increases (all P < 0.05). The apoptosis 
rate in the ERS + 4-PBA group was not significantly different from that in the blank group (P > 0.05). Compared with the ERS group, the apoptosis rate was significantly decreased in the ERS + 4-PBA group (all P < 0.05); no significant difference was found in the rapamycin group (all P > 0.05), but the apoptosis rate was increased in the ERS + rapamycin group (all P < 0.05) (Fig. 7) .
p53 LC Cells Undergoing ERS have Reduced DDP Drug Resistance
Compared to observations made in the blank group, the cell inhibition rate in the ERS group was significantly upregulated when treated with DDP at concentrations of 25, 50, 100, 200, and 400 µmol/l (all P < 0.05). The inhibition rate in the ERS + 4-PBA group was not significantly different when compared with the blank group (all P > 0.05). With 
ERS Decreases the Proliferation of Mutant p53 LC Cells
In the H322 cells, after treatment with 200 µmol/l DDP, the number of BrdU positive cells in the blank, ERS, ERS + 4-PBA, rapamycin, and ERS + rapamycin groups was 64, 34, 60, 36 and 11, respectively (Fig. 8A & C) . In the NCI-H157 cells, after treatment with 200 µmol/l DDP, the number of BrdU positive cells in the blank, ERS, ERS + 4-PBA, rapamycin, and ERS + rapamycin groups was 66, 35, 61, 35 and 10, respectively (Fig. 8B & D) . Among these two cell types, the number of BrdU positive cells in the ERS, rapamycin and ERS + rapamycin groups was significantly lower than that in the blank and ERS + 4-PBA groups (all P < 0.05). The number of BrdU positive cells in the ERS + rapamycin group was notably lower than that in the rapamycin group, while the number of BrdU positive cells in the ERS + 4-PBA group was obviously higher than in that of the ERS group (all P < 0.05). Table 4 . Effects of different concentrations of cisplatin on the inhibition rate of mutant p53 H322 LC cells in the blank, the ERS, the ERS + 4-PBS, the Rapamycin and the ERS + Rapamycin groups respectively. Notes: * represents the comparison with the blank group (P < 0.05);
# represents the comparison with the ERS group (P < 0.05); ERS, endoplasmic reticulum stress; 4-PBA, phenylbutyrate acid Table 5 . Effects of different concentrations of cisplatin on the inhibition rate of mutant p53 NCI-H157 LC cells in the blank, the ERS, the ERS + 4-PBS, the Rapamycin and the ERS + Rapamycin groups respectively. Notes:
* represents the comparison with the blank group (P < 0.05); # represents the comparison with the ERS group (P < 0.05); ERS, endoplasmic reticulum stress; 4-PBA, phenylbutyrate acid Table 6 . The comparison of clone formation ability of mutant p53 H322 LC cells in the blank, the ERS, the ERS + 4-PBS, the Rapamycin and the ERS + Rapamycin groups respectively. Notes:
* represents the comparison with the blank group (P < 0.05);
# represents the comparison with the ERS group (P < 0.05); & represents the comparison with the Rapamycin group (P < 0.05); ERS, endoplasmic reticulum stress; 4-PBA, phenylbutyrate acid Cellular Physiology and Biochemistry
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ERS Increases Colony Formation in H322 Cells
In the H322 cell line, after treatment with 200 µmol/l DDP, the colony formation rates in the blank, ERS, ERS + 4-PBA, rapamycin, and ERS + rapamycin groups were 45.18%, 35.27%, 19.22%, 34.89% and 18.85%, respectively (Table 6 ). In the NCI-H157 cell line, after treatment with 200 µmol/l DDP, the colony formation rates in the blank, ERS, ERS + 4-PBA, rapamycin and ERS + rapamycin groups were 44.62%, 36.04%, 19.78%, 34.67% and 19.74%, respectively ( Table 7) . The colony formation rates of both cell lines in the ERS group, the rapamycin group and the ERS + rapamycin group were lower than in those of the blank group and the ERS + 4-PBA group (all P < 0.05). The colony formation rate in the ERS + rapamycin group was lower than that of the rapamycin group (P < 0.05). The colony formation rate in the ERS + 4-PBA group was higher than that in the ERS group (P < 0.05). 
Discussion
LC currently represents for one of the leading malignant tumors worldwide. In the present study, we demonstrated that in mutant p53 LC, ERS is highly prevalent and that the PI3K/AKT/mTOR signaling pathway is upregulated. Additionally, our findings provided evidence indicating that ERS contributes to autophagy, apoptosis and reduces chemotherapy resistance in mutant p53 LC cells through the downregulation of the PI3K/AKT/mTOR signaling pathway.
The results of our experiment highlighted that patients with mutant p53 LC have a poorer response to chemotherapy than patients with wild-type p53. Genetically, carcinogenesis involves multiple processes by which the activation of oncogenes and the inactivation of tumor suppressor genes represent central factors for tumor development and progression of the disease [33] . Tumor suppressor mutations, as reported in LC cells, may contribute to the pathogenesis of invasive cancer [12] . p53 is widely known as a tumor suppressor, while wild-type p53 has been linked with apoptosis, cell cycle arrest, and DNA repair [34] . Conversely, the loss of p53 due to mutations induces various types of human cancers [35] owing to the fact that mutant p53 can cause aberrant mitosis and reduce apoptosis [14] . Mutant p53 can also promote proliferation, invasion, and migration and increase genomic instability and chemoresistance [36] . Studies conducted by Lei et al. revealed that mutant p53 and poor tumor differentiation were correlated with poor prognoses in LC [37] . These findings were in concert with the results of our study, in regard to the prevalence of ERS in mutant p53 LC tissues.
Furthermore, when rapamycin was applied, the LC cells exhibited elevated LC3, Atg5, Atg7, caspase-3, and caspase-12 levels; more autophagosomes; increased cell apoptosis; and decreased tumor diameters. A previous study found that over-expression of miR-144 suppressed proliferation and promoted apoptosis and autophagy in LC cells by targeting the p53-induced glycolysis and apoptosis regulator, which was consistent with our results [38] . When ERS was inhibited by 4-PBA, the autophagy factors and apoptotic factors also in turn displayed reduced levels. The cancer cells had reduced apoptosis and increased drug resistance. LC3-II/LC3-I, Atg7, and Atg5 are autophagy-related gene transcripts [39] . Located on the ER cytoplasmic surface, caspase-12 is a key biomarker of ERS-specific apoptosis [40, 41] . Caspase-3 is a cysteine protease, which are pro-apoptotic proteins with prominent roles in ERS-induced cell death [42, 43] . ERS is well-characterized in human LC [44, 45] . Recent evidence has suggested that ERS can initiate internal pathways that may induce cellular death [27] . The central objective of the ERS response is to limit disturbance and ultimately recover ER balance; however, in terms of intense or sustained ERS, these pathways will activate programmed cell apoptosis [46] . Calcium imbalance or aberrant protein folding in the ER result in ERS and induce cell destruction responses [47, 48] . Alterations in the ER molecular chaperone levels can suppress tumor growth in vivo [44] . Likewise, ERS-induced apoptosis is also highly dependent on the upregulation of CHOP [49] . CHOP is the best-characterized factor in the transition from ERS to cell apoptosis [50] . CHOP-knockdown cells are resistant to cell apoptosis that is usually induced by ERS [16] , that can lead to various processes, including autophagy and apoptosis, which function as the regulators of cell survival and death [19, 20] . ERS can also activate the unfolded protein response, which reports have earmarked due to their role in chemotherapeutic resistance or antitumor therapy based on the stimuli and cell context [51] . GRP78, a molecular chaperone protein and a member of the heat shock protein-70 family, is critical for tumor progression and chemoresistance. GRP78 has also been shown to be negatively associated with cell survival [52] . Jiang et al. revealed that ERS upregulates GRP78 protein levels in human pancreatic cancer cells [53] . In mammalian cells, IRE1α mediates ER stress and is both necessary and sufficient for apoptosis [54] . Shimodaira et al. demonstrated that CHOP promotes IRE1α and autophagy, especially under ER stress conditions [55] .
The PI3K/AKT/mTOR pathway is significantly decreased in mutant p53 LC cells. The PI3K/AKT/mTOR pathway is an important target due to its regulatory role in various cancers Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry [24, 56, 57] ; it is also involved in the invasion and metastasis and progression of hepatocellular carcinoma, cervical cancer, and LC [22, 25, 58] . ERS shares a correlation with the PI3K/Akt/ mTOR signaling pathway. Our experimental data revealed that increases in ERS are followed by decreases in PI3K/AKT/mTOR signaling, as well as reductions in chemoresistance; when the PI3K/AKT/mTOR signaling pathway is blocked, autophagy and apoptosis factors are increased, chemotherapy resistance is weakened, and the tumor shrinks [27, 59] , which has an important function in autophagy and apoptosis regulation [2, 60, 61] . It has been reported that blocking the PI3K/AKT/mTOR cascade promotes autophagy [62] that inhibiting PI3K/ Akt/mTOR signaling promotes cell apoptosis in LC [28] , which is consistent with our results.
Conclusion
Our study provides new insight into the mechanism connecting ERS and the PI3K/AKT/ mTOR signaling pathway in LC progression. Our findings provided evidence highlighting that ERS promotes cell autophagy and apoptosis and reduces the chemotherapeutic resistance of mutant p53 LC cells via downregulating the PI3K/AKT/mTOR signaling pathway. These results offer important information for understanding and managing mutant p53 LC.
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